Mc Carthy Asset Management, Inc. Abb Vie Inc. Transaction History

Mc Carthy Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $88,489 - $112,499	-643 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $131 - $163	1 Added 0.16%	643 $104,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $106 - $120	1 Added 0.16%	642 $69,000
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $195,690 - $218,010	-1,860 Reduced 74.37%	641 $72,000
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $20,971 - $23,087	-205 Reduced 7.58%	2,501 $271,000
Q4 2020 Feb 01, 2021	BUY	$80.49 - $108.67 $217,805 - $294,061	2,706 New	2,706 $290,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Mc Carthy Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Carthy Asset Management, Inc. with notifications on news.